Subscriptions are live: We're on the subscription model now, early-access price $24.99/month, with day, week, and longer plans too. New accounts start with 5 free premium days. Prefer to donate? Donations grant premium time and are logged on your profile page.

$BIVI

BioVie, Inc. Common Stock

XNAS

$1.65+0.63%+$0.0103Prev $1.64LIVE Full chart Live alerts
No recent price bars, the chart lights up when BIVI starts printing.

As of the latest tick, BIVI is trading at $1.65, up 0.63% versus the previous close of $1.64.

Key Stats

Price
$1.65
Change today
+0.63%
Previous close
$1.64
52-week range
$1.06 – $9.09
Avg daily volume
156K
Exchange
XNAS

Why is $BIVI up today?

Here is the latest on BIVI from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for BIVI today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.

Auto-generated from live scanner data. Not investment advice.

$BIVI Sentiment

Bullish
Bearish69Bullish
📰 News: 4 bull · 1 bearToday: +0.6%👥 Community: 0 bull · 0 bear

Blend of news sentiment, today’s move, and community votes. Not investment advice.

$BIVI Activity

News, unusual-volume alerts, AI-trader trades and community chatter — the whole story, newest first.

Alert· 17h ago -3.37%
$BIVI moved -3.37% in 1 min (Level 3) at 10:44 AM ET
at $1.95
News· GlobeNewswire Inc.· 236d ago Bullish
Join Biovie’s Exclusive Live Investor Webinar and Q&A Session on December 9
News· GlobeNewswire Inc.· 290d ago Bullish
BioVie to Host Live Investor Webinar and Q&A on Oct. 8
News· Benzinga· 340d ago Neutral
BioVie Inc. Announces Pricing of $12 Million Public Offering
News· GlobeNewswire Inc.· 340d ago Neutral
BioVie Inc. Announces Pricing of $12 Million Public Offering
News· GlobeNewswire Inc.· 354d ago Bullish
BioVie Presented Data Highlighting that Patients Treated with Bezisterim Potentially Experienced an Age Deceleration Advantage Compared to Placebo on 10 Different Biological Clocks at the 2nd World Conference on Aging and Gerontology
News· GlobeNewswire Inc.· 370d ago Neutral
Alzheimer’s Therapeutics Market on Upward Trajectory Across the 7MM During the Forecast Period (2025–2034) Fueled by Drug Development Advances | DelveInsight
News· GlobeNewswire Inc.· 439d ago Bearish
BIOVIE ALERT: Bragar Eagel & Squire, P.C. is Investigating BioVie Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
News· GlobeNewswire Inc.· 453d ago Bullish
BioVie Initiates SUNRISE-PD Clinical Trial Assessing Bezisterim in Early Parkinson’s Disease with First Patient Enrolled
Free alerts

Get free $BIVI alerts the moment volume spikes

Our scanner flagged $BIVI 1 time in the last 30 days. Create a free account to track $BIVI, build a watchlist, and get instant unusual-volume alerts — plus 5 free premium days, no card needed.

Real-time RVOL & momentum alerts Personal watchlist & price alerts
Sign up free with email

No card · 5 premium days · join 800+ traders

BIVI stock FAQ

Why is $BIVI up today?

Here is the latest on BIVI from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for BIVI today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.

What is the BIVI stock price today?

BIVI last traded at $1.65, up 0.63% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).

Where can I see live BIVI alerts?

The BIVI Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged BIVI 1 time in the last 30 days.

What exchange is BIVI on?

BIVI (BioVie, Inc. Common Stock) trades on XNAS.

Is BIVI good for day trading?

That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge BIVI for yourself. This is not investment advice.

Live data from TheDesperateTrader scanner. Not investment advice.